Literature DB >> 16597708

Antibiotic use and risk of multiple sclerosis.

Alvaro Alonso1, Susan S Jick, Hershel Jick, Miguel A Hernán.   

Abstract

Some reports suggest that bacteria, including Chlamydophila pneumoniae, could be involved in the etiology of multiple sclerosis. If that is true, persons who used antibiotics active against these bacteria, compared with nonusers, might be at lower risk of multiple sclerosis. Using a 1993-2000 case-control study nested in the United Kingdom-based General Practice Research Database cohort, the authors identified 163 multiple sclerosis cases who were followed up for at least 3 years before their first symptoms (the index date). Up to 10 controls matched to the cases by age, sex, general practice, and time in the cohort were selected. Exposure to antibiotics was assessed through computerized medical records. Overall antibiotic use or use of antibiotics against C. pneumoniae was not associated with multiple sclerosis risk. However, use of penicillins in the 3 years before the index date decreased the risk of developing a first attack of multiple sclerosis (odds ratio=0.5, 95% confidence interval: 0.3, 0.9 for those who used penicillins for >or=15 days compared with no use). In conclusion, use of antibiotics active against C. pneumoniae was not associated with a decreased risk of short-term multiple sclerosis. The observed lower risk of multiple sclerosis for penicillin users needs to be confirmed in other populations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16597708     DOI: 10.1093/aje/kwj123

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  11 in total

Review 1.  Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping.

Authors:  Ippazio Cosimo Antonazzo; Emanuel Raschi; Luca Vignatelli; Elisa Baldin; Trond Riise; Roberto D'Alessandro; Fabrizio De Ponti; Elisabetta Poluzzi
Journal:  Drug Saf       Date:  2017-09       Impact factor: 5.606

Review 2.  The hygiene hypothesis in autoimmunity: the role of pathogens and commensals.

Authors:  Jean-François Bach
Journal:  Nat Rev Immunol       Date:  2017-10-16       Impact factor: 53.106

3.  Dominant Antibiotic Consumption Patterns Might Be Associated With the Prevalence of Multiple Sclerosis in European Countries.

Authors:  GÁbor TernÁk; KÁroly BerÉnyi; Gergely MÁrovics; AndrÁs SÜmegi; Barbara Fodor; BalÁzs NÉmeth; IstvÁn Kiss
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

Review 4.  Microbiota Signaling Pathways that Influence Neurologic Disease.

Authors:  Laura M Cox; Howard L Weiner
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

Review 5.  Risk factors associated with the onset of relapsing-remitting and primary progressive multiple sclerosis: a systematic review.

Authors:  Kyla A McKay; Vivian Kwan; Thomas Duggan; Helen Tremlett
Journal:  Biomed Res Int       Date:  2015-01-31       Impact factor: 3.411

6.  Epidemiology of multiple sclerosis: results from a large observational study in the UK.

Authors:  Susan S Jick; L Li; G J Falcone; Z P Vassilev; M-A Wallander
Journal:  J Neurol       Date:  2015-06-13       Impact factor: 4.849

Review 7.  The Beneficial and Debilitating Effects of Environmental and Microbial Toxins, Drugs, Organic Solvents and Heavy Metals on the Onset and Progression of Multiple Sclerosis.

Authors:  Mahmood Y Hachim; Noha M Elemam; Azzam A Maghazachi
Journal:  Toxins (Basel)       Date:  2019-03-05       Impact factor: 4.546

Review 8.  Infections, Vaccines and Autoimmunity: A Multiple Sclerosis Perspective.

Authors:  Dejan Jakimovski; Bianca Weinstock-Guttman; Murali Ramanathan; Michael G Dwyer; Robert Zivadinov
Journal:  Vaccines (Basel)       Date:  2020-01-28

9.  Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?

Authors:  Bernd Krone; John M Grange
Journal:  BMC Neurol       Date:  2013-07-18       Impact factor: 2.474

10.  Mortality of patients with multiple sclerosis: a cohort study in UK primary care.

Authors:  S S Jick; L Li; G J Falcone; Z P Vassilev; M-A Wallander
Journal:  J Neurol       Date:  2014-05-18       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.